Roger Susi Sells 5,000 Shares of iRadimed (NASDAQ:IRMD) Stock

iRadimed Corporation (NASDAQ:IRMD) CEO Roger Susi sold 5,000 shares of the firm’s stock in a transaction dated Monday, October 6th. The stock was sold at an average price of $71.72, for a total transaction of $358,600.00. Following the transaction, the chief executive officer directly owned 2,342,500 shares of the company’s stock, valued at $168,004,100. The trade was a 0.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

iRadimed Stock Performance

NASDAQ:IRMD opened at $76.87 on Thursday. The company has a 50-day moving average of $71.00 and a 200-day moving average of $60.77. The company has a market capitalization of $977.79 million, a price-to-earnings ratio of 47.45 and a beta of 1.02. iRadimed Corporation has a 52 week low of $46.86 and a 52 week high of $77.88.

iRadimed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Monday, August 18th were given a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.9%. The ex-dividend date was Monday, August 18th. iRadimed’s dividend payout ratio (DPR) is presently 41.98%.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “buy (b-)” rating on shares of iRadimed in a research report on Wednesday. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat, iRadimed currently has an average rating of “Buy” and an average target price of $72.00.

Institutional Investors Weigh In On iRadimed

Several institutional investors have recently modified their holdings of IRMD. Roubaix Capital LLC acquired a new stake in shares of iRadimed during the 1st quarter worth approximately $2,526,000. SG Americas Securities LLC grew its position in shares of iRadimed by 408.8% during the 2nd quarter. SG Americas Securities LLC now owns 36,516 shares of the medical equipment provider’s stock worth $2,183,000 after buying an additional 29,339 shares during the period. Nuveen LLC acquired a new position in iRadimed during the first quarter valued at approximately $1,418,000. Johnson Investment Counsel Inc. acquired a new position in iRadimed during the second quarter valued at approximately $1,534,000. Finally, Vanguard Group Inc. grew its holdings in iRadimed by 3.3% during the first quarter. Vanguard Group Inc. now owns 554,451 shares of the medical equipment provider’s stock valued at $29,098,000 after purchasing an additional 17,640 shares during the period. Institutional investors and hedge funds own 92.34% of the company’s stock.

iRadimed Company Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.